Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker

Hypertension

Volumn 61, Issue 1, 2013, Pages

  Frau, Francesca ^a   Citterio, Lorena ^b   Ortu, Maria Francesca ^c   Zaninello, Roberta ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY HOSPITAL OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; HYDROCHLOROTHIAZIDE; LOSARTAN;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTENSION; LETTER; PHARMACOGENOMICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERTENSION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84871606848     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.201426     Document Type: Letter

References (3)

1. Turner ST, Bailey KR, Schwartz GL, Chapman AB, Chai HS, Boerwinkle E. Genomic association analysis identifes multiple loci infuencing anti-hypertensive response to an angiotensin II receptor blocker. Hypertension. 2012;59:1204-11.
2. Glorioso N, Argiolas G, Filigheddu F, Troffa C, Cocco F, Bulla E, Bulla P, Zaninello R, Degortes S, Pitzoi S, Frau F, Fadda S, Pinna Parpaglia P, Bernini G, Bardini M, et al; Study Group on Cardiovascular Pharmacogenomics of Italian Society of Hypertension. Conceptual basis and methodology of the SOPHIA study. Pharmacogenomics. 2007;8:1497-509. (Pubitemid 350286395)
3. Salvi E, Kutalik Z, Glorioso N, Benaglio P, Frau F, Kuznetsova T, Arima H, Hoggart C, Tichet J, Nikitin YP, Conti C, Seidlerova J, Tikhonoff V, Stolarz-Skrzypek K, Johnson T, et al. Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifes a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase. Hypertension. 2012;59:248-55.